NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 9.50% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 8.19% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.94% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.68% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.65% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.21% |
0QIU | Novo Nordisk A/S Class B | 3.88% | ||
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.68% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 3.67% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.58% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 3.52% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.21% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 3.01% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.75% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.62% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.22% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.83% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.67% |
7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 1.66% |